Drug shortage: Methylphenidate Hydrochloride Tablet, Extended Release (RELEXXII, METHYLPHENIDATE HYDROCHLORIDE, CONCERTA)
FDA lists 34 presentations as Current. Availability: Unavailable (6), Limited Availability (9), Available (19). Reason: Discontinuation of the manufacture of the drug; Demand increase for the drug. Companies: Sun Pharmaceutical Industries, Inc., Vertical Pharmaceuticals, LLC, Teva Pharmaceuticals USA, Inc., Lannett Company, Inc., Trigen Laboratories, LLC….
- Published by source
- 2023-07-26
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- Products
- Methylphenidate Hydrochloride Tablet, Extended Release RELEXXII METHYLPHENIDATE HYDROCHLORIDE CONCERTA
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Currently not marketed
- Allocation to current contracted customers
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2023-07-26
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #922 | new | 2026-10-22 | e2afc27c91f1…db384c | 30ed44dfea6c…c061bc |
Chain head: #1076 8ad5adc30b9b…88ce20